Company Overview
Snapshot
Founded in May 2017 by Igor Gindin, CaleeTech operates with 11–50 employees. The company graduated from the SHAAR Healthcare Innovation Hub in April 2024, marking a key development in its journey.
Business overview
CaleeTech is a biotechnology startup focused on developing novel solutions for individuals with obesity and diabetes. The company's core product is an oral formulation designed to reduce caloric intake by limiting the absorption of fats and sugars in the small intestine. This beverage aims to enable users to enjoy meals while significantly lowering calorie absorption and blood sugar/fat levels. CaleeTech operates within the Health Tech & Life Sciences sector, specifically targeting pharmaceuticals and food tech industries with its non-invasive, transient product.
Strategic signal
CaleeTech's graduation from the SHAAR Healthcare Innovation Hub in April 2024 signals a significant advancement in its product development and market readiness. This milestone indicates that the company has successfully completed a structured program designed to accelerate healthcare innovations, suggesting a validated business model and potential for commercialization in the health tech and life sciences sectors.
Log in to access full profile ›Company Intelligence Q&A
- When was CaleeTech founded?
- CaleeTech was founded in May 2017.
- Who is the founder of CaleeTech?
- Igor Gindin is the founder and CEO of CaleeTech.
- What significant program did CaleeTech complete in 2024?
- In April 2024, CaleeTech graduated from the SHAAR Healthcare Innovation Hub.
- Has CaleeTech received any funding from investors?
- CaleeTech received Pre-Seed funding in June 2022 from Israel MedicUp.
- Which innovation lab did CaleeTech participate in?
- CaleeTech participated in the FoodNxt innovation lab in March 2019.